Literature DB >> 25157109

Dysbindin-1C is required for the survival of hilar mossy cells and the maturation of adult newborn neurons in dentate gyrus.

Hao Wang1, Yefeng Yuan1, Zhao Zhang1, Hui Yan2, Yaqin Feng2, Wei Li3.   

Abstract

DTNBP1 (dystrobrevin-binding protein 1), which encodes dysbindin-1, is one of the leading susceptibility genes for schizophrenia. Both dysbindin-1B and -1C isoforms are decreased, but the dysbindin-1A isoform is unchanged in schizophrenic hippocampal formation, suggesting dysbindin-1 isoforms may have distinct roles in schizophrenia. We found that mouse dysbindin-1C, but not dysbindin-1A, is localized in the hilar glutamatergic mossy cells of the dentate gyrus. The maturation rate of newborn neurons in sandy (sdy) mice, in which both dysbindin-1A and -1C are deleted, is significantly delayed when compared with that in wild-type mice or with that in muted (mu) mice in which dysbindin-1A is destabilized but dysbindin-1C is unaltered. Dysbindin-1C deficiency leads to a decrease in mossy cells, which causes the delayed maturation of newborn neurons. This suggests that dysbindin-1C, rather than dysbindin-1A, regulates adult hippocampal neurogenesis in a non-cell autonomous manner.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apoptosis; Autophagy; BLOC-1; Dysbindin-1; Hippocampus; Neurogenesis; Schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 25157109      PMCID: PMC4200260          DOI: 10.1074/jbc.M114.590927

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.

Authors:  M A Benson; S E Newey; E Martin-Rendon; R Hawkes; D J Blake
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

Review 2.  Hermansky-Pudlak syndrome: pigmentary and non-pigmentary defects and their pathogenesis.

Authors:  Ai-Hua Wei; Wei Li
Journal:  Pigment Cell Melanoma Res       Date:  2012-12-31       Impact factor: 4.693

3.  The gene for the muted (mu) mouse, a model for Hermansky-Pudlak syndrome, defines a novel protein which regulates vesicle trafficking.

Authors:  Qing Zhang; Wei Li; Edward K Novak; Amna Karim; Vishnu S Mishra; Stephen F Kingsmore; Bruce A Roe; Tamio Suzuki; Richard T Swank
Journal:  Hum Mol Genet       Date:  2002-03-15       Impact factor: 6.150

4.  Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.

Authors:  W Bailey Glen; Bryant Horowitz; Gregory C Carlson; Tyrone D Cannon; Konrad Talbot; J David Jentsch; Antonieta Lavin
Journal:  Hippocampus       Date:  2013-11-12       Impact factor: 3.899

5.  Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.

Authors:  Jennifer Larimore; Stephanie A Zlatic; Avanti Gokhale; Karine Tornieri; Kaela S Singleton; Ariana P Mullin; Junxia Tang; Konrad Talbot; Victor Faundez
Journal:  J Biol Chem       Date:  2014-04-08       Impact factor: 5.157

6.  BLOC-1, a novel complex containing the pallidin and muted proteins involved in the biogenesis of melanosomes and platelet-dense granules.

Authors:  Juan M Falcón-Pérez; Marta Starcevic; Rashi Gautam; Esteban C Dell'Angelica
Journal:  J Biol Chem       Date:  2002-05-17       Impact factor: 5.157

7.  The schizophrenia susceptibility gene DTNBP1 modulates AMPAR synaptic transmission and plasticity in the hippocampus of juvenile DBA/2J mice.

Authors:  Ian J Orozco; Peter Koppensteiner; Ipe Ninan; Ottavio Arancio
Journal:  Mol Cell Neurosci       Date:  2013-12-07       Impact factor: 4.314

8.  Identification of snapin and three novel proteins (BLOS1, BLOS2, and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1).

Authors:  Marta Starcevic; Esteban C Dell'Angelica
Journal:  J Biol Chem       Date:  2004-04-21       Impact factor: 5.157

9.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.

Authors:  Richard E Straub; Yuxin Jiang; Charles J MacLean; Yunlong Ma; Bradley T Webb; Maxim V Myakishev; Carole Harris-Kerr; Brandon Wormley; Hannah Sadek; Bharat Kadambi; Anthony J Cesare; Avi Gibberman; Xu Wang; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler
Journal:  Am J Hum Genet       Date:  2002-07-03       Impact factor: 11.025

10.  Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1).

Authors:  Wei Li; Qing Zhang; Naoki Oiso; Edward K Novak; Rashi Gautam; Edward P O'Brien; Caroline L Tinsley; Derek J Blake; Richard A Spritz; Neal G Copeland; Nancy A Jenkins; Dominick Amato; Bruce A Roe; Marta Starcevic; Esteban C Dell'Angelica; Rosemary W Elliott; Vishnu Mishra; Stephen F Kingsmore; Richard E Paylor; Richard T Swank
Journal:  Nat Genet       Date:  2003-08-17       Impact factor: 38.330

View more
  16 in total

1.  SLC35D3 increases autophagic activity in midbrain dopaminergic neurons by enhancing BECN1-ATG14-PIK3C3 complex formation.

Authors:  Zong-Bo Wei; Ye-Feng Yuan; Florence Jaouen; Mei-Sheng Ma; Chan-Juan Hao; Zhe Zhang; Quan Chen; Zengqiang Yuan; Li Yu; Corinne Beurrier; Wei Li
Journal:  Autophagy       Date:  2016-05-12       Impact factor: 16.016

2.  TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.

Authors:  Ankush Borlepawar; Ashraf Yusuf Rangrez; Alexander Bernt; Lynn Christen; Samuel Sossalla; Derk Frank; Norbert Frey
Journal:  J Biol Chem       Date:  2017-05-02       Impact factor: 5.157

Review 3.  The enigmatic mossy cell of the dentate gyrus.

Authors:  Helen E Scharfman
Journal:  Nat Rev Neurosci       Date:  2016-07-28       Impact factor: 34.870

4.  Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes.

Authors:  Emilie I Petit; Zuzanna Michalak; Rachel Cox; Colm M P O'Tuathaigh; Niamh Clarke; Orna Tighe; Konrad Talbot; Derek Blake; Josephine Joel; Alexander Shaw; Steven A Sheardown; Alastair D Morrison; Stephen Wilson; Ellen M Shapland; David C Henshall; James N Kew; Brian P Kirby; John L Waddington
Journal:  Neuropsychopharmacology       Date:  2016-12-16       Impact factor: 7.853

5.  Biogenesis of lysosome-related organelles complex-1 subunit 1 (BLOS1) interacts with sorting nexin 2 and the endosomal sorting complex required for transport-I (ESCRT-I) component TSG101 to mediate the sorting of epidermal growth factor receptor into endosomal compartments.

Authors:  Aili Zhang; Xin He; Ling Zhang; Lin Yang; Philip Woodman; Wei Li
Journal:  J Biol Chem       Date:  2014-09-02       Impact factor: 5.157

6.  BLOS2 negatively regulates Notch signaling during neural and hematopoietic stem and progenitor cell development.

Authors:  Wenwen Zhou; Qiuping He; Chunxia Zhang; Xin He; Zongbin Cui; Feng Liu; Wei Li
Journal:  Elife       Date:  2016-10-10       Impact factor: 8.140

Review 7.  Dysbindin-1 Involvement in the Etiology of Schizophrenia.

Authors:  Haitao Wang; Jiangping Xu; Philip Lazarovici; Wenhua Zheng
Journal:  Int J Mol Sci       Date:  2017-09-22       Impact factor: 5.923

Review 8.  Potential implications of a monosynaptic pathway from mossy cells to adult-born granule cells of the dentate gyrus.

Authors:  Helen E Scharfman; Hannah L Bernstein
Journal:  Front Syst Neurosci       Date:  2015-08-19

9.  Increased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation.

Authors:  Yiliang Xu; Yuhui Sun; Haihong Ye; Li Zhu; Jianghong Liu; Xiaofeng Wu; Le Wang; Tingting He; Yan Shen; Jane Y Wu; Qi Xu
Journal:  Cell Discov       Date:  2015-11-10       Impact factor: 10.849

Review 10.  Biological implications of genetic variations in autism spectrum disorders from genomics studies.

Authors:  Yue Zhang; Xuanshi Liu; Ruolan Guo; Wenjian Xu; Qi Guo; Chanjuan Hao; Xin Ni; Wei Li
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.